Questioning the evidence behind the saturation model for testosterone replacement therapy in prostate cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jin Wook | - |
dc.date.available | 2020-08-04T02:22:04Z | - |
dc.date.issued | 2020-05 | - |
dc.identifier.issn | 2466-0493 | - |
dc.identifier.issn | 2466-054X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/42824 | - |
dc.description.abstract | Published in 2009, the Saturation Model suggested that there were limits to which androgen encouraged growth of the prostate. This was, in particular, applied to prostate cancer, where conventional wisdom since Huggins has considered it almost taboo for a patient being treated with cancer to receive testosterone replacement therapy (TRT). Since then, several studies began to investigate the application of TRT in, at first, mild and stable prostate cancer patients. While early reports seem promising, the validity of the Saturation Model had not been addressed. The current review investigates the evidence synthesis behind the Saturation Model, based on its original publication where it was presented. The evidence reviewed includes in vitro, in vivo and clinical studies that were referenced as the basis when the model was presented. Despite promising associations, the evidence employed were troublingly taken out of context in many cases and applied freely in cases where it would be unwise to do so. In light of some shortcomings in evidence synthesis, we advise some caution when applying the Saturation Model in prostate cancer. © The Korean Urological Association. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Korean Urological Association | - |
dc.title | Questioning the evidence behind the saturation model for testosterone replacement therapy in prostate cancer | - |
dc.type | Article | - |
dc.identifier.doi | 10.4111/icu.2020.61.3.242 | - |
dc.identifier.bibliographicCitation | Investigative and Clinical Urology, v.61, no.3, pp 242 - 249 | - |
dc.identifier.kciid | ART002585461 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 000530626400002 | - |
dc.identifier.scopusid | 2-s2.0-85084220512 | - |
dc.citation.endPage | 249 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 242 | - |
dc.citation.title | Investigative and Clinical Urology | - |
dc.citation.volume | 61 | - |
dc.identifier.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189106/ | - |
dc.type.docType | Review | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Androgen receptor | - |
dc.subject.keywordAuthor | Androgens | - |
dc.subject.keywordAuthor | Hypogonadism | - |
dc.subject.keywordAuthor | Prostatic neoplasms | - |
dc.subject.keywordAuthor | Testosterone | - |
dc.subject.keywordPlus | androgen receptor | - |
dc.subject.keywordPlus | gonadotropin | - |
dc.subject.keywordPlus | prostate specific antigen | - |
dc.subject.keywordPlus | androgen therapy | - |
dc.subject.keywordPlus | cancer model | - |
dc.subject.keywordPlus | cancer risk | - |
dc.subject.keywordPlus | epigenetics | - |
dc.subject.keywordPlus | follow up | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | metastasis | - |
dc.subject.keywordPlus | nonhuman | - |
dc.subject.keywordPlus | phenotype | - |
dc.subject.keywordPlus | prostate cancer | - |
dc.subject.keywordPlus | radioimmunoassay | - |
dc.subject.keywordPlus | randomized controlled trial (topic) | - |
dc.subject.keywordPlus | Review | - |
dc.subject.keywordPlus | risk factor | - |
dc.subject.keywordPlus | testosterone blood level | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.